These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 38396888)

  • 21. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?
    Musa S
    Arab J Gastroenterol; 2020 Mar; 21(1):3-8. PubMed ID: 32253172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the correlation between COVID-19 and the progression of chronic liver disease.
    Philips CA; Madhu D; Augustine P
    Expert Rev Gastroenterol Hepatol; 2023; 17(6):603-613. PubMed ID: 37086388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A review].
    Maev IV; Osadchuk MA
    Ter Arkh; 2022 Dec; 94(11):1326-1332. PubMed ID: 37167173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COVID-19 and liver disease.
    Dufour JF; Marjot T; Becchetti C; Tilg H
    Gut; 2022 Nov; 71(11):2350-2362. PubMed ID: 35701093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 and liver injury: An ongoing challenge.
    Papagiouvanni I; Kotoulas SC; Pataka A; Spyratos DG; Porpodis K; Boutou AK; Papagiouvannis G; Grigoriou I; Vettas C; Goulis I
    World J Gastroenterol; 2023 Jan; 29(2):257-271. PubMed ID: 36687117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and liver disease: mechanistic and clinical perspectives.
    Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 and alcohol associated liver disease.
    Deutsch-Link S; Curtis B; Singal AK
    Dig Liver Dis; 2022 Nov; 54(11):1459-1468. PubMed ID: 35933291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
    Saviano A; Wrensch F; Ghany MG; Baumert TF
    Hepatology; 2021 Aug; 74(2):1088-1100. PubMed ID: 33332624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.
    Perisetti A; Gajendran M; Mann R; Elhanafi S; Goyal H
    Dis Mon; 2020 Sep; 66(9):101064. PubMed ID: 32807535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
    Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
    Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor outcomes in patients with cirrhosis and Corona Virus Disease-19.
    Shalimar ; Elhence A; Vaishnav M; Kumar R; Pathak P; Soni KD; Aggarwal R; Soneja M; Jorwal P; Kumar A; Khanna P; Singh AK; Biswas A; Nischal N; Dar L; Choudhary A; Rangarajan K; Mohan A; Acharya P; Nayak B; Gunjan D; Saraya A; Mahapatra S; Makharia G; Trikha A; Garg P
    Indian J Gastroenterol; 2020 Jun; 39(3):285-291. PubMed ID: 32803716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal and hepatic involvement during COVID-19 pandemic: A focus on pediatric population and possible future implications.
    Sica R; Pennoni S; Penta L; Riccioni S; Di Cara G; Verrotti A
    World J Gastroenterol; 2021 Oct; 27(40):7000-7004. PubMed ID: 34790020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms implicated in SARS-CoV-2 liver tropism.
    Quarleri J; Delpino MV
    World J Gastroenterol; 2022 Dec; 28(48):6875-6887. PubMed ID: 36632318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
    Boye A; Zou YH; Yang Y
    World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 induced hepatic injuries and liver complications.
    Saeed U; Piracha ZZ; Uppal SR; Waheed Y; Uppal R
    Front Cell Infect Microbiol; 2022; 12():726263. PubMed ID: 36189356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.